Navigation Links
Northeastern's Barnett Institute announces formation of leading analytics company, BioAnalytix, LLC
Date:9/18/2012

Biologic drugs represent one of the most important and fastest growing areas in healthcare today, and especially as these biopharmaceuticals begin to come off patent and developers prepare for biosimilars to hit the market, there is a growing need for advanced analytics throughout the drug development process.

The Barnett Institute of Chemical and Biological Analysis, a part of Northeastern University's College of Science, has recognized this need, and has partnered in the formation of BioAnalytix, LLCa company specializing in the application of advanced biologic drug characterization methods and technologies to enable better, faster and more effective drug development and commercialization.

With a strong and experienced board from the analytical sciences and pharmaceutical industry, the Barnett Institute wanted to help create a company that could directly serve pharmaceutical partners in key areas of biologic development. "Beyond its well established research position in advanced analytics, the Barnett Institute has for several yearsbeen working with leading pharmaceutical companies to develop and apply analytical methods in their areas of biologic development, and we continued to see the increasing opportunity to meet this need as a commercially orientedbusiness," said Barry Karger, Director of the Barnett Institute, James L. Waters Chair in Analytical Chemistry.

"It is really a terrific opportunity to bring leading research and advanced analytic capabilities into a business that can directly help improve and accelerate drug development processes, and reduce costs in the healthcare space overall," said BioAnalytix CEO, Kirt Poss.

The affiliation between the Barnett Institute and BioAnalytix will also enable a mutually beneficial opportunity in joint participation in leading research and policy areas, as well as increased project work with partners in combined areas of advanced research and commercial application,providing even more unique and applied opportunities for Northeastern students. "The spin-off of BioAnalytix not only leads to socially beneficial commercial development that we are not suited to do inside a university, but also keeps our research in contact with the cutting edge of technology in the biologic sector," said Murray Gibson, Dean of Northeastern's College of Science.


'/>"/>

Contact: Lori Lennon
l.lennon@neu.edu
617-680-5129
Northeastern University College of Science
Source:Eurekalert

Related medicine news :

1. Penn Translational Medicine Institute to hold 7th Annual Symposium
2. Scripps Research Institute scientists show protein linked to hunger also implicated in alcoholism
3. Weizmann Institutes mathematical model may lead to safer chemotherapy
4. Cedars-Sinai Heart Institute awarded $1.3 million to study cardiac stem cells
5. Astex, CRT and the Institute of Cancer Research announce epigenetic drug discovery collaboration
6. Johns Hopkins Armstrong Institute receives $8.9 million patient safety grant
7. Minneapolis Heart Institute Foundation welcomes Europace publication of Optim lead insulation paper
8. Minneapolis Heart Institute Foundation welcomes Europace publication of Optim™ lead insulation paper
9. Researchers awarded National Cancer Institute grants aimed at answering provocative questions
10. JDRF-Helmsley Charitable Trust to fund islet encapsulation research at Diabetes Research Institute
11. A vaccine for heart disease? La Jolla Institute discovery points up this possibility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... ... August 18, 2017 , ... As an industry leader, Eppendorf ... they will present the line of epMotion automated liquid handling system. This automated ... automate everyday pipetting tasks. , Ideal for scientists and lab technicians with no ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... planning services to communities in east Texas, is launching a regional charity effort ... , Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) has raised nearly ...
(Date:8/18/2017)... ... August 18, 2017 , ... The Golseth Agency, a Texas based ... area, is spearheading a regional charity campaign organized to provide support to Christina Upchurch ... of this year, Christina and her children returned from out of town to find ...
(Date:8/18/2017)... ... ... Alcovit, a lime-flavored beverage that rids the body of toxins linked to alcohol ... through Jet.com. , After 25 years of development, the company released its highly ... detox the body thereby avoiding alcohol-induced hangovers. Whether you’re having fun with friends or ...
(Date:8/18/2017)... (PRWEB) , ... August 18, 2017 , ... “Dangerous Inheritance”: ... published author, Diane Winters. Diane is from Southwest Nebraska where she was raised ... friends and family. The story is fictional, but the friendships and mantra of ...
Breaking Medicine News(10 mins):
(Date:8/17/2017)... Bio-Ess Laboratories, LLC Chief Science Officer, Dr. Adam Elhofy , will ... Cell-Ess® Universal Titer Boost at the 9 th annual ... 21-25.  The Bioprocessing Summit convenes more than 1,000 international bioprocess professionals to ... ... Cell-Ess is the ...
(Date:8/15/2017)... FLINT, Mich. , Aug. 15, 2017 ... antidote naloxone to Michigan residents. ... Diplomat,s Flint retail pharmacy, G-3320 ... Naloxone, approved by the Food and Drug Administration, is ... drugs—including extreme drowsiness, slowed breathing, and loss of consciousness. ...
(Date:8/15/2017)... , Aug. 15, 2017 AccuGenomics, Inc., ... , today announced that the company has provided ... University of North Carolina at Chapel Hill and to ... designed to characterize and quantify HIV reservoir and viral ... pharmacological intervention. The HIV Cure Center is a joint ...
Breaking Medicine Technology: